These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 16307884

  • 1. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV.
    Ersmark K, Nervall M, Gutiérrez-de-Terán H, Hamelink E, Janka LK, Clemente JC, Dunn BM, Gogoll A, Samuelsson B, Qvist J, Hallberg A.
    Bioorg Med Chem; 2006 Apr 01; 14(7):2197-208. PubMed ID: 16307884
    [Abstract] [Full Text] [Related]

  • 2. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
    Gutiérrez-de-Terán H, Nervall M, Ersmark K, Liu P, Janka LK, Dunn B, Hallberg A, Aqvist J.
    Biochemistry; 2006 Sep 05; 45(35):10529-41. PubMed ID: 16939205
    [Abstract] [Full Text] [Related]

  • 3. High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II.
    Nöteberg D, Schaal W, Hamelink E, Vrang L, Larhed M.
    J Comb Chem; 2003 Sep 05; 5(4):456-64. PubMed ID: 12857114
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H, Nervall M, Dunn BM, Clemente JC, Aqvist J.
    FEBS Lett; 2006 Oct 30; 580(25):5910-6. PubMed ID: 17045991
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV.
    Boss C, Corminboeuf O, Grisostomi C, Meyer S, Jones AF, Prade L, Binkert C, Fischli W, Weller T, Bur D.
    ChemMedChem; 2006 Dec 30; 1(12):1341-5. PubMed ID: 17091526
    [No Abstract] [Full Text] [Related]

  • 9. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
    Binkert C, Frigerio M, Jones A, Meyer S, Pesenti C, Prade L, Viani F, Zanda M.
    Chembiochem; 2006 Jan 30; 7(1):181-6. PubMed ID: 16307463
    [Abstract] [Full Text] [Related]

  • 10. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
    Nöteberg D, Hamelink E, Hultén J, Wahlgren M, Vrang L, Samuelsson B, Hallberg A.
    J Med Chem; 2003 Feb 27; 46(5):734-46. PubMed ID: 12593654
    [Abstract] [Full Text] [Related]

  • 11. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
    Abdel-Rahman HM, Kimura T, Hidaka K, Kiso A, Nezami A, Freire E, Hayashi Y, Kiso Y.
    Biol Chem; 2004 Nov 27; 385(11):1035-9. PubMed ID: 15576323
    [Abstract] [Full Text] [Related]

  • 12. Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
    Azim MK, Ahmed W, Khan IA, Rao NA, Khan KM.
    Bioorg Med Chem Lett; 2008 May 01; 18(9):3011-5. PubMed ID: 18417344
    [Abstract] [Full Text] [Related]

  • 13. Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors.
    Ahmed W, Rani M, Khan IA, Iqbal A, Khan KM, Haleem MA, Azim MK.
    J Enzyme Inhib Med Chem; 2010 Oct 01; 25(5):673-8. PubMed ID: 20063996
    [Abstract] [Full Text] [Related]

  • 14. alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.
    Orrling KM, Marzahn MR, Gutiérrez-de-Terán H, Aqvist J, Dunn BM, Larhed M.
    Bioorg Med Chem; 2009 Aug 15; 17(16):5933-49. PubMed ID: 19635672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
    Hidaka K, Kimura T, Tsuchiya Y, Kamiya M, Ruben AJ, Freire E, Hayashi Y, Kiso Y.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3048-52. PubMed ID: 17400453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D, Gulnik S, Collins L, Gustchina E, Suvorov L, Erickson JW.
    Biochemistry; 1997 Dec 23; 36(51):16166-72. PubMed ID: 9405050
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.